Unknown

Dataset Information

0

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.


ABSTRACT: FGFR3 is a prognostic and predictive marker and is a validated therapeutic target in urothelial bladder cancer. Its utility as a marker and target in the context of immunotherapy is incompletely understood. We review the role of FGFR3 in bladder cancer and discuss preclinical and clinical clues of its effectiveness as a patient selection factor and therapeutic target in the era of immunotherapy.

SUBMITTER: Kacew A 

PROVIDER: S-EPMC7674585 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>FGFR3</i> Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.

Kacew Alec A   Sweis Randy F RF  

Frontiers in immunology 20201105


<i>FGFR3</i> is a prognostic and predictive marker and is a validated therapeutic target in urothelial bladder cancer. Its utility as a marker and target in the context of immunotherapy is incompletely understood. We review the role of <i>FGFR3</i> in bladder cancer and discuss preclinical and clinical clues of its effectiveness as a patient selection factor and therapeutic target in the era of immunotherapy. ...[more]

Similar Datasets

| S-EPMC3641081 | biostudies-literature
| S-EPMC3888214 | biostudies-literature
| S-EPMC8445627 | biostudies-literature
| S-EPMC3554204 | biostudies-literature
| S-EPMC5883337 | biostudies-literature
| S-EPMC9654607 | biostudies-literature
| S-EPMC4350803 | biostudies-literature
| S-EPMC7246793 | biostudies-literature
| S-EPMC10722136 | biostudies-literature
| S-EPMC8656749 | biostudies-literature